Effectiveness and safety of rivaroxaban versus warfarin for treatment of cancer-associated venous thrombosis

Introduction: Treatment of cancer-associated venous thrombosis (CAT) is challenging due to patients ’ increased risk of recurrent venous thromboembolism (VTE) and bleeding. CAT treatment guidelines recommend oral anticoagulation (OAC) be reserved for patients unable or unwilling to use long-term parenteral therapy but do not differentiate between warfarin and direct-acting OACs.

Source: Thrombosis Research - April 1, 2018 Category: Hematology Authors: C.I. Coleman, T.J. Bunz, C.G. Kohn, J. Beyer-Westendorf Source Type: research